- Home
- FMAO vs ANGO Comparison
FMAO vs ANGO Comparison
Compare FMAO & ANGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FMAO
- ANGO
- Stock Information
- Founded
- FMAO 1897
- ANGO 1988
- Country
- FMAO United States
- ANGO United States
- Employees
- FMAO N/A
- ANGO N/A
- Industry
- FMAO Savings Institutions
- ANGO Medical/Dental Instruments
- Sector
- FMAO Finance
- ANGO Health Care
- Exchange
- FMAO Nasdaq
- ANGO Nasdaq
- Market Cap
- FMAO 356.9M
- ANGO 400.8M
- IPO Year
- FMAO N/A
- ANGO 2004
- Fundamental
- Price
- FMAO $26.75
- ANGO $9.45
- Analyst Decision
- FMAO
- ANGO Strong Buy
- Analyst Count
- FMAO 0
- ANGO 3
- Target Price
- FMAO N/A
- ANGO $19.00
- AVG Volume (30 Days)
- FMAO 21.4K
- ANGO 364.4K
- Earning Date
- FMAO 07-28-2025
- ANGO 10-02-2025
- Dividend Yield
- FMAO 3.59%
- ANGO N/A
- EPS Growth
- FMAO 38.39
- ANGO N/A
- EPS
- FMAO 2.16
- ANGO N/A
- Revenue
- FMAO $108,632,000.00
- ANGO $292,498,000.00
- Revenue This Year
- FMAO N/A
- ANGO $7.13
- Revenue Next Year
- FMAO $6.16
- ANGO $6.28
- P/E Ratio
- FMAO $11.42
- ANGO N/A
- Revenue Growth
- FMAO 13.86
- ANGO N/A
- 52 Week Low
- FMAO $20.88
- ANGO $5.83
- 52 Week High
- FMAO $34.15
- ANGO $13.50
- Technical
- Relative Strength Index (RSI)
- FMAO 59.68
- ANGO 60.20
- Support Level
- FMAO $24.60
- ANGO $8.65
- Resistance Level
- FMAO $25.36
- ANGO $9.20
- Average True Range (ATR)
- FMAO 0.95
- ANGO 0.32
- MACD
- FMAO 0.15
- ANGO 0.11
- Stochastic Oscillator
- FMAO 93.15
- ANGO 90.08
About FMAO Farmers & Merchants Bancorp Inc.
Farmers & Merchants Bancorp Inc is a holding company based in Ohio. The company is engaged in general commercial banking business. The activities of the company include commercial, agricultural and residential mortgages as well as consumer and credit card lending activities.
About ANGO AngioDynamics Inc.
AngioDynamics Inc designs manufactures, and sells medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and for use in oncology and surgical settings. Geographically, the company derives a majority of its revenue from the United States from sale of Med Tech and Med Device.